Gaucher disease paradigm: from ERAD to comorbidity.

Gaucher disease paradigm: from ERAD to comorbidity.

Item
http://www.wikidata.org/entity/Q38012690
Glucocerebrosidase is shaking up the synucleinopathiesA Novel Functional Missense Mutation p.T219A in Type 1 Gaucher's Disease.Using pharmacological chaperones to restore proteostasisMutant glucocerebrosidase in Gaucher disease recruits Hsp27 to the Hsp90 chaperone complex for proteasomal degradationCelastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones.Functional analysis of 11 novel GBA alleles.Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.Unfolded protein response in Gaucher disease: from human to Drosophila.Bicyclic derivatives of L-idonojirimycin as pharmacological chaperones for neuronopathic forms of Gaucher disease.ERdj3 is an endoplasmic reticulum degradation factor for mutant glucocerebrosidase variants linked to Gaucher's disease.A systematic investigation of iminosugar click clusters as pharmacological chaperones for the treatment of Gaucher disease.Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease.
P2860

Gaucher disease paradigm: from ERAD to comorbidity.

Item
http://www.wikidata.org/entity/Q38012690
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Gaucher disease paradigm: from ERAD to comorbidity.
@en
type
label
Gaucher disease paradigm: from ERAD to comorbidity.
@en
prefLabel
Gaucher disease paradigm: from ERAD to comorbidity.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Gaucher disease paradigm: from ERAD to comorbidity.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698